Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Efficacy of Chemical Genicular Nerve Neurolysis Using Alcohol or Phenol Versus Radiofrequency Ablation Under Ultrasound Guidance for Pain Management in Patients With Knee Osteoarthritis

NCT06798038 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06798038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06798038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Efficacy of Chemical Genicular Nerve Neurolysis Using Alcohol or Phenol Versus Radiofrequency Ablation Under Ultrasound Guidance for Pain Management in Patients With Knee Osteoarthritis
Lead sponsor
Tanta University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
March 1, 2027
Enrollment
105 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

assessment of knee function using the western ontario and mcmaster universities osteoarthritis index (womac), assessment of pain intensity using 10-point numerical rating scale (nrs-10)(9)immediately after intervention , 1 week,1month,3 months,6months and one year, knee osteoarthritis